Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
09:03am, Tuesday, 08'th Oct 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Undervalued Dividend Kings: October 2024
09:00am, Tuesday, 08'th Oct 2024
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges. I rank Dividend Kings by quality score and highlight undervalued stocks for pote
Cramer's Stop Trading: Abbott Labs
10:22am, Monday, 07'th Oct 2024
CNBC's Jim Cramer explains why he is keeping an eye on shares of Abbott Labs.
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
04:45am, Saturday, 05'th Oct 2024
Investors can find market-trouncing blue chip stocks in the healthcare industry.
PAHC or ABT: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 04'th Oct 2024
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two companies is the best option for those looking for under
Abbott (ABT) Outperforms Broader Market: What You Need to Know
07:06pm, Wednesday, 02'nd Oct 2024
Abbott (ABT) concluded the recent trading session at $113.64, signifying a +0.07% move from its prior day's close.
Will Abbott (ABT) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Tuesday, 01'st Oct 2024
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Abbott, Reckitt face trial over premature baby formula amid alarm from doctors
08:03am, Monday, 30'th Sep 2024
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott , Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she
2 Excellent Dividend Stocks to Buy With Less Than $200
05:00am, Saturday, 28'th Sep 2024
Abbott Laboratories' top line was somewhat inconsistent in recent years due to swings in its COVID-related revenues. Johnson & Johnson has been restructuring, spinning off its consumer health segment
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Friday, 27'th Sep 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 27'th Sep 2024
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
My Best Dividend Aristocrats For October 2024
09:19am, Friday, 27'th Sep 2024
The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aris
Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know
07:05pm, Thursday, 26'th Sep 2024
Abbott (ABT) closed the most recent trading day at $112.73, moving +0.11% from the previous trading session.
To help address the greatest need for blood in a generation, Abbott, a global leader in blood testing, and the Big Ten Conference are teaming up to host the first college conference-wide blood donatio
Abbott Hosts Conference Call for Third-Quarter Earnings
09:00am, Wednesday, 25'th Sep 2024
ABBOTT PARK, Ill., Sept. 25, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2024 financial results on Wednesday, Oct. 16, before the market opens.
